期刊文献+

Gastrointestinal complications after kidney transplantation 被引量:10

在线阅读 下载PDF
导出
摘要 Gastrointestinal complications are common after renal transplantation,and they have a wide clinical spectrum,varying from diarrhoea to post-transplant inflammatory bowel disease(IBD).Chronic immunosuppression may increase the risk of post-transplant infection and medication-related injury and may also be responsible for IBD in kidney transplant re-cipients despite immunosuppression.Differentiating the various forms of post-transplant colitis is challenging,since most have similar clinical and histological features.Drug-related colitis are the most frequently encountered colitis after kidney transplantation,particularly those related to the chronic use of mycophenolate mofetil,while de novo IBDs are quite rare.This review will explore colitis after kidney transplantation,with a particular focus on different clinical and histological features,attempting to clearly identify the right treatment,thereby improving the final outcome of patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2020年第38期5797-5811,共15页 世界胃肠病学杂志(英文版)
基金 Supported by FIR 2014 Project,University of Catania.
  • 相关文献

参考文献1

二级参考文献10

  • 1Udayakumar Navaneethan,Preethi G.K. Venkatesh,Saurabh Mukewar,Bret A. Lashner,Feza H. Remzi,Arthur J. McCullough,Ravi P. Kiran,Bo Shen,John J. Fung.Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis[J].Clinical Gastroenterology and Hepatology.2012(5)
  • 2Ibrahim A.Hanouneh,CaroleMacaron,RocioLopez,Nizar N.Zein,Bret A.Lashner.Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis[J].Inflamm Bowel Dis.2012(2)
  • 3A. Indriolo,S. Fagiuoli,L. Pasulo,G. Fiorino,S. Danese,P. Ravelli.Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation[J].Aliment Pharmacol Ther.2013(8)
  • 4A. B. Mohabbat,W. J. Sandborn,E. V. Loftus,R. H. Wiesner,D. H. Bruining.Anti‐tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients[J].Aliment Pharmacol Ther.2012(6)
  • 5Kristin Kaasen J?rgensen,Lina Lindstr?m,Milada Cvancarova,Maria Castedal,Styrbj?rn Friman,Erik Schrumpf,Aksel Foss,Helena Isoniemi,Arno Nordin,Kathrine Holte,Allan Rasmussen,Annika Bergquist,Morten H Vatn,Kirsten Muri Boberg.Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study[J].Scandinavian Journal of Gastroenterology (-).2012(8-9)
  • 6A. Sandhu,T. Alameel,C. H. Dale,M. Levstik,N. Chande.The safety and efficacy of antitumour necrosis factor‐alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series[J].Aliment Pharmacol Ther.2012(2)
  • 7A. Indriolo,S. Fagiuoli,L. Pasulo,A. Sonzogni,M. Colledan,G. Fiorino,S. Danese,P. Ravelli.P270 Infliximab in patients with ulcerative colitis and primary sclerosing cholangitis before and after liver transplatation[J].Journal of Crohn’s and Colitis.2012
  • 8Deepak Joshi,Ingvar Bjarnason,Ajay Belgaumkar,John O’Grady,Abid Suddle,Michael A. Heneghan,Varuna Aluvihare,Mohammed Rela,Nigel Heaton,Kosh Agarwal.The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis[J].Liver Int.2011(1)
  • 9J. Temme,M. Koziolek,C. Bramlage,I.M. Schaefer,L. Füzesi,G. Ramadori,G.A. Müller,H. Schw?rer.Infliximab as Therapeutic Option in Steroid-Refractory Ulcerative Colitis after Kidney Transplantation: Case Report[J].Transplantation Proceedings.2010(9)
  • 10J. B.Albright,H.Bonatti,J.Stauffer,R. C.Dickson,J.Nguyen,D.Harnois,C.Jeanpierre,R.Hinder,J.Steers,H.Chua,J.Aranda‐Michel.Colorectal and anal neoplasms following liver transplantation[J].Colorectal Disease.2010(7)

共引文献4

同被引文献65

引证文献10

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部